JP Morgan Chase & Co (JPM) 68.01 $JPM Citigroup's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
JP Morgan Chase & Co (JPM) 68.01 $JPM

Citigroup's Mexican Unit Under DOJ Probe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 4:59PM CDT
Citigroup Inc.'s (C) wholly owned subsidiary, Banamex (Banco Nacional de Mexico) USA, was hit with a money-laundering probe last Friday. Notably, The U.S. Department of Justice ("DOJ" is investigating whether Banamex USA allowed customers to transfer illegal cash through its Mexican unit.
GS: 205.02 (-2.33), JPM: 68.01 (-0.90), C: 57.96 (-0.74), HSBC: 43.89 (-0.18)

Kroll Bond Rating Agency Assigns Preliminary Ratings to J.P. Morgan Mortgage Trust 2015-5 (JPMMT 2015-5)
Business Wire - Mon Jul 27, 4:25PM CDT
Kroll Bond Rating Agency, Inc. (KBRA) assigns preliminary ratings to 29 classes of mortgage pass-through certificates from J.P. Morgan Mortgage Trust 2015-5 (JPMMT 2015-5), a prime jumbo RMBS transaction.
JPM: 68.01 (-0.90)

Look for Shares of JPMorgan Chase to Potentially Rebound after Yesterday's 1.31% Sell Off
Comtex SmarTrend(R) - Mon Jul 27, 3:52PM CDT
JPMorgan Chase (NYSE:JPM) traded in a range yesterday that spanned from a low of $67.57 to a high of $68.22. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $68.68 on volume of 16.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JPM: 68.01 (-0.90)

After Yesterday's Decline of 1.31%, JPMorgan Chase Offers Investors Better Value
Comtex SmarTrend(R) - Mon Jul 27, 3:51PM CDT
JPMorgan Chase (NYSE:JPM) traded in a range yesterday that spanned from a low of $67.57 to a high of $68.22. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $68.68 on volume of 16.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
JPM: 68.01 (-0.90)

What's in Store for Sony (SNE) This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 27, 3:41PM CDT
Sony Corporation (SNE) is set to report first quarter fiscal 2015 results on Jul 30.
ANTM: 151.50 (+0.64), JPM: 68.01 (-0.90), SNE: 28.88 (-0.39), AMED: 43.44 (-0.74)

Planet Fitness Sets Terms For $203 Million IPO
at Investor's Business Daily - Mon Jul 27, 12:30PM CDT
Planet Fitness set terms for an initial public offering that looks to raise $203 million for the franchisers and operators of fitness centers. Planet Fitness will offer 13.5 million shares at a price range of 14 to 16. It will list on the NYSE under...
FIT: 43.93 (-1.61), JPM: 68.01 (-0.90)

J.P. Morgan Retirement Insights Compares Custom and "Off-the-Shelf" Target Date Strategies, Outlines Benefits and Challenges for Plan Sponsors and Financial Advisors
PR Newswire - Mon Jul 27, 10:17AM CDT
J.P. Morgan Asset Management today released its latest Retirement Insights paper outlining best practices for selecting a target date strategy for defined contribution plans (DC). The white paper, "Custom or off-the-shelf target date strategies?," explores several factors - such as asset allocation, management selection and fee structure - that DC plan sponsors and financial advisors should carefully consider when deciding whether a custom or "off-the-shelf" target date strategy is most appropriate for their plan. Key findings include:
JPM: 68.01 (-0.90)

Top 10 Hottest Stocks on Social Media Last Week
at The Street - Mon Jul 27, 9:39AM CDT
What did the social-media universe have to say about stocks last week? Here's the a round-up of most-discussed stocks.
TSLA: 253.01 (-12.40), SYT: 81.25 (-1.93), MON: 101.46 (-1.40), JPM: 68.01 (-0.90), FOX: 32.29 (-0.54), GDOT: 19.53 (-0.12), SNE: 28.88 (-0.39), PSO: 17.98 (-0.80), DIS: 118.25 (-0.66), CVS: 109.77 (-0.72), MXL: 11.05 (+0.23), CMCSA: 61.11 (-1.06), ACN: 100.39 (-0.78), TWX: 86.54 (-0.84)

Planet Fitness, Inc. Launches Initial Public Offering
GlobeNewswire - Mon Jul 27, 6:01AM CDT
Planet Fitness, Inc. ("Planet Fitness" or the "Company" today announced that it has commenced an initial public offering of 13,500,000 shares of its Class A common stock. The underwriters will have a 30-day option to purchase up to an additional 2,025,000 shares of common stock. The price range for the initial public offering is currently estimated to be between $14 and $16 per share. The Company has applied to list its Class A common stock on the New York Stock Exchange under the ticker symbol "PLNT."
JPM: 68.01 (-0.90), PLNT: ()

Why Oil Carnage Doesn't Equal Poor Oil Service Earnings
Tyler Crowe and Taylor Muckerman, The Motley Fool - Motley Fool - Sat Jul 25, 11:30AM CDT
The earnings reports are still filing in and the energy sector is one that's been on the forefront of most investors' minds. Three of the four major companies all showed promise with growth in an otherwise desperate energy sector. As Baker Hughes ...
JPM: 68.01 (-0.90), CHK: 8.37 (+0.09), HAL: 40.98 (-0.74), XOM: 79.26 (-0.68), WFC: 57.59 (-0.19), SLB: 81.76 (-1.14), CLB: 104.32 (+0.02), BHI: 57.74 (-0.92)

Fitch Expects to Rate J.P. Morgan Mortgage Loan Trust 2015-5; Presale Issued
Business Wire - Fri Jul 24, 4:36PM CDT
Fitch Ratings expects to rate J.P. Mortgage Loan Trust 2015-5 (JPMMT 2015-5) as follows:
JPM: 68.01 (-0.90)

Bank Stock Roundup: Q2 Earnings in Final Stretch; Comerica, SunTrust, Citi in Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 4:00PM CDT
In the last five trading days, earnings releases were in full swing for banking stocks.
CFR: 70.75 (-1.13), FITB: 20.85 (-0.29), RF: 10.41 (-0.15), COF: 78.61 (-0.25), JPM: 68.01 (-0.90), C: 57.96 (-0.74), STI: 43.92 (-0.39), BK: 43.26 (-0.46), HCBK: 10.26 (-0.13), CMA: 46.63 (-1.23)

JPMorgan Chase (JPM) Crosses Pivot Point Support at $69.20
Comtex SmarTrend(R) - Fri Jul 24, 1:09PM CDT
Shares of JPMorgan Chase (NYSE:JPM) opened today below their pivot of $69.90 and have already reached the first level of support at $69.20. Analysts will be watching for a cross of the next downside pivot targets of $68.75 and $67.60.
JPM: 68.01 (-0.90)

How You Can Avoid the Sting of a Market Correction
at The Street - Fri Jul 24, 12:18PM CDT
If history is any indication, U.S. markets are overdue for a correction, but a few tweaks to your portfolio can make a pullback a bit less painful.
JPM: 68.01 (-0.90), EUFN: 23.24 (-0.19)

Fitch Affirms JPMCC 2012-C8
Business Wire - Thu Jul 23, 3:29PM CDT
Fitch Ratings has affirmed 13 classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2012-C8 commercial mortgage pass-through certificates series 2012-C8 (JPMCC 2012-C8). A detailed list of rating actions follows at the end of this press release.
JPM: 68.01 (-0.90)

Citigroup to Pay $140M Fine, Shut Down Banamex USA Unit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 2:13PM CDT
Putting an end to the regulatory probe over its three-branch Banamex (Banco Nacional de Mexico) USA subsidiary, Citigroup Inc. (C) has decided to shut down the unit. Notably, the closure follows on the agreement by Citigroup to pay $140 million as settlement to regulators over loopholes in its anti-money laundering (AML) program.
GS: 205.02 (-2.33), JPM: 68.01 (-0.90), C: 57.96 (-0.74), DB: 32.71 (-0.51)

Don't Sell Qualcomm; Stick With Companies That Have Growth
at The Street - Thu Jul 23, 2:04PM CDT
The CNBC 'Fast Money' traders debate whether now is a good time to sell Qualcomm, and discuss a raft of other stocks.
AMZN: 531.41 (+1.99), NKE: 111.73 (-1.26), FB: 94.17 (-2.78), PFE: 34.34 (+0.08), C: 57.96 (-0.74), LLY: 84.15 (-0.57), BMY: 64.30 (-1.68), INTC: 28.35 (+0.29), HPQ: 30.25 (-0.56), FINL: 26.83 (-0.11), NFLX: 106.43 (-2.91), UA: 96.43 (+0.38), JPM: 68.01 (-0.90), IBM: 159.07 (-0.68), QCOM: 61.98 (+0.34), FFIV: 127.81 (+0.32), CRUS: 32.90 (-1.31), GOOGL: 658.27 (+3.50), FL: 68.79 (-0.64), AAPL: 122.77 (-1.73), FTNT: 47.10 (-0.89), CSCO: 28.21 (-0.19)

Comcast New CFO: Word On Buybacks Due In January
at Investor's Business Daily - Thu Jul 23, 12:44PM CDT
Comcast (CMCSA) shareholders anxious to hear about 2016 stock buybacks will wait as customary until the cable TV and media company releases Q4 earnings in January, says its new chief financial officer, who plans to keep investing in NBCUniversal and...
JPM: 68.01 (-0.90), CHTR: 181.88 (-2.45), TWC: 188.14 (-2.95), CMCSA: 61.11 (-1.06)

Bootstrapping Execs Woo Potential Co-Founders
at Investor's Business Daily - Thu Jul 23, 12:21PM CDT
Smart entrepreneurs seek strength in numbers. How they court co-founders: Join forces. "There's a saying: If you want to go fast, go alone. If you want to go far, go with a team." So says Satyen Sangani, CEO of Alation, which means "to have wings."...
JPM: 68.01 (-0.90), LNKD: 220.66 (-4.40), GOOGL: 658.27 (+3.50), AAPL: 122.77 (-1.73)

'Showdown Year' for Cyber-Attacks Has Hackers Demanding Ransom in Bitcoin
at The Street - Thu Jul 23, 6:41AM CDT
Regulators are urging companies to ramp up cyber-security systems to protect both their own businesses and their customers' data as Finra recounts extortion attempts by hackers seeking ransom in Bitcoin.
HD: 113.07 (-0.52), GS: 205.02 (-2.33), JPM: 68.01 (-0.90), EBAY: 28.00 (-0.23), MS: 39.25 (-0.35)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 22

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 28

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 23

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 22

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 24

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Revolutionizes Trading: Insights from FBS Analysts

Updated Category News Views 358

AI's Impact on Trading: Key Developments and Insights In recent years, artificial intelligence (AI) has significantly influenced various industries, and trading is no exception. FBS, a prominent global broker, has conducted a deep dive into this revolutionary shift. They emphasize how AI is enhancing the efficiency, accuracy, and overall decision-making processes in...

Continue Reading
Alerus Financial Corp: Anticipated Earnings Report Insights

Updated Category News Views 131

Insights into Alerus Financial Corp’s Upcoming Earnings Alerus Finl (NASDAQ: ALRS) is gearing up to share its quarterly earnings report on a forthcoming Monday. Investors are on the edge of their seats, eagerly anticipating insights into the company’s performance and forecasts for the upcoming quarter. Analysts predict that Alerus Finl will achieve an earnings per...

Continue Reading
DXC Technology Unveils London Center to Enhance AI Solutions

Updated Category News Views 133

DXC Technology Unveils New Customer Experience Center in London DXC Technology (NYSE: DXC), a prominent enterprise technology partner, has recently inaugurated its Customer Experience Center in London. This center is set to transform how businesses harness artificial intelligence (AI) by assisting them in moving from merely experimenting with AI technologies to achieving...

Continue Reading
Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT

Updated Category News Views 188

Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT Coave Therapeutics, a leader in genetic medicine innovation, recently presented compelling data regarding its advanced suprachoroidal capsid, coAAV-SCS-01, at the European Society of Gene and Cell Therapy Congress 2025 held in Seville. This innovative capsid has shown to outperform traditional capsids,...

Continue Reading
HealthPRO Canada Celebrates Work Culture Achievement Again

Updated Category News Views 215

HealthPRO Canada's Continued Commitment to Excellence HealthPRO Canada, a prominent provider of group contracting for healthcare, proudly announces its status as a Great Place to Work® for the fourth consecutive year. This recognition highlights the organization’s dedication to fostering a supportive and inclusive work environment. Understanding the Great Place to...

Continue Reading